Household products giant Reckitt Benckiser has been accused by the Office of Fair Trading (OFT) of rigging the market for heartburn drug Gaviscon. It claims the firm sought to restrict competition in ...

Background Medical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon®, 4 × ...

Struggling with heartburn or acid reflux? We explain how to buy the best and cheapest over the counter medicines, and when to seek help Award-winning senior researcher/writer with 25 years' experience ...

A product that many Aussies rely on daily has been hit with a global shortage due to one very specific – and peculiar – reason. If you suffer from heartburn or indigestion then you know how important ...

As Reckitt Benckiser last week debuts Gaviscon in the country to check incidences of reflux disease among Nigerians, particularly pregnant women, experts have said that reflux disease is under ...

A global shortage of infant Gaviscon is causing frustration among GPs, who are having to completely change treatment for babies with reflux. The powder sachets for gastro-oesophageal reflux disease in ...

Household products giant Reckitt Benckiser has agreed to pay a £10.2m fine after admitting to abusing its market position for the supply of heartburn drug Gaviscon. The Office of Fair Trading (OFT) ...

Shoppers are being warned that shortages of popular medicines including Calpol and Lemsip are affecting high street shelves. Stores across the country are reportedly in short supply of some of the ...

Gaviscon maker Reckitt Benckiser faces an OFT investigation after a whistleblower accused it of forcing NHS doctors to offer patients a more expensive version of the indigestion medicine. The Office ...

A heartbroken widow has told how her partner died after doctors dismissed his deadly health condition for stomach issues and sent him home with Gaviscon. David Burgess, from Sale, Greater Manchester, ...

The GOOD trial was a 14-day multicentre randomised double-blind double-dummy non-inferiority trial comparing efficacy between Gaviscon® and omeprazole 20 mg. It recruited 90 general practitioners (GPs ...